Auro Laboratories Limited (BOM:530233)
India · Delayed Price · Currency is INR 231.10
-3.65 (-1.55%)
At close: Jul 31, 2026
Auro Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,440 | 1,652 | 1,437 | 1,004 | 341 | 625 | |
Market Cap Growth | -14.47% | 14.94% | 43.06% | 194.93% | -45.52% | 23.67% |
Enterprise Value | 2,060 | 2,084 | 1,772 | 1,088 | 381 | 528 |
Last Close Price | 231.10 | 265.00 | 230.55 | 161.15 | 54.64 | 100.30 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 40.77 | 46.75 | 78.15 | 12.89 | 13.95 | 21.98 |
PS Ratio | 4.69 | 5.37 | 7.51 | 1.87 | 0.64 | 1.23 |
PB Ratio | 3.11 | 3.56 | 3.34 | 2.39 | 1.00 | 1.98 |
P/TBV Ratio | 3.11 | 3.56 | 3.34 | 2.39 | 1.00 | 1.98 |
P/OCF Ratio | 68.16 | 78.16 | 28.62 | 5.34 | 10.38 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 6.70 | 6.78 | 9.27 | 2.03 | 0.72 | 1.04 |
EV/EBITDA Ratio | 20.17 | 20.42 | 56.64 | 10.20 | 8.67 | 11.41 |
EV/EBIT Ratio | 27.84 | 28.17 | 87.19 | 11.36 | 11.48 | 14.62 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.37 | 1.37 | 1.05 | 0.63 | 0.19 | 0.44 |
Debt / EBITDA Ratio | 6.20 | 6.20 | 14.39 | 2.46 | 1.46 | 2.98 |
Net Debt / Equity Ratio | 1.34 | 1.34 | 1.05 | 0.60 | 0.14 | 0.04 |
Net Debt / EBITDA Ratio | 6.07 | 6.07 | 14.39 | 2.37 | 1.05 | 0.30 |
Net Debt / FCF Ratio | -1.13 | -1.13 | -2.40 | -1.50 | -5.83 | -0.12 |
Asset Turnover | 0.28 | 0.28 | 0.21 | 0.76 | 0.95 | 1.05 |
Inventory Turnover | 0.74 | 0.74 | 1.56 | 2.70 | 4.51 | 9.87 |
Quick Ratio | 0.37 | 0.37 | 0.52 | 0.84 | 1.07 | 1.45 |
Current Ratio | 1.08 | 1.08 | 0.96 | 1.29 | 1.97 | 1.87 |
Return on Equity (ROE) | 7.91% | 7.91% | 4.33% | 20.46% | 7.43% | 9.47% |
Return on Assets (ROA) | 4.20% | 4.20% | 1.38% | 8.45% | 3.74% | 4.66% |
Return on Invested Capital (ROIC) | 5.57% | 5.54% | 2.56% | 13.61% | 6.56% | 9.84% |
Return on Capital Employed (ROCE) | 8.00% | 8.00% | 2.60% | 15.50% | 8.80% | 10.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.45% | 2.14% | 1.28% | 7.76% | 7.17% | 4.55% |
FCF Yield | -38.20% | -33.32% | -13.07% | -16.76% | -2.33% | -17.92% |